Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 9 September 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.

Under the programme initiated 9 August 2019, Novo Nordisk will repurchase B shares for an amount up to DKK 2.6 billion in the period from 9 August 2019 to 30 October 2019.

Since the announcement as of 2 September 2019, the following transactions have been made:

 Number of
B shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement2,054,000 712,638,600
2 September 2019125,000356.7944,598,316
3 September 2019125,000360.2945,036,143
4 September 2019120,000363.1243,574,297
5 September 2019130,000359.4046,722,098
6 September 2019120,000356.6042,792,518
Accumulated under the programme2,674,000 935,361,972

The details for each transaction made under the share repurchase programme are published on novonordisk.com.

With the transactions stated above, Novo Nordisk owns a total of 33,234,044 B shares of DKK 0.20, corresponding to 1.4% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,400,000,000 including treasury shares.

Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 1 February 2019. As of 6 September 2019, Novo Nordisk has since 1 February 2019 repurchased a total of 26,075,012 B shares at an average share price of DKK 328.68 per B share equal to a transaction value of DKK 8,570,315,427.


Further information

Media:  
Anne Margrethe Hauge+45 4442 3450amhg@novonordisk.com
Ken Inchausti (US)+1 609 240 9429kiau@novonordisk.com
   
Investors:  
Peter Hugreffe Ankersen+45 3075 9085phak@novonordisk.com
Valdemar Borum Svarrer+45 3079 0301jvls@novonordisk.com
Ann Søndermølle Rendbæk+45 3075 2253arnd@novonordisk.com
Kristoffer Due Berg (US)+1 609 235 2989krdb@novonordisk.com
   


Company announcement no. 52 / 2019

Attachment